TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Use of granulocyte colony-stimulating factors
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Full attrition rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Partial attrition rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum inflammatory factor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hourly ropivacaine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial and complete responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reconstruction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: hunger reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with cancer therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Receiving the tetanus toxoid injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Consulting a doctor if spotting or bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Delivering in hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Median total fibroid load reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of the largest fibroid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median nonperfused volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Streptococcus mutans bacterial density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in body dissatisfaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in binge eating days/week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular Pressure (IOP) agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort of IOP measurements
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Median number of hypotensive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-weighted average of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvements in academic skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: percentage of patients requiring additional morphine
Endpoint domain: Adverse events/effects
Primary endpoint: pain scores at 8, 12, and 24 h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICU stay length
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Predictive efficiency for prognosis of acute stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with medical counselling and pamphlet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Open communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: superior humeral translation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to reach peak automaticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plaque indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Change in AIS from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CGI-I from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with AIS less than 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kt/V increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phosphate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving CV target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in COPM-performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in COPM-satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: prevention of clinical malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tissue necrosis
Endpoint domain: Adverse events/effects
Primary endpoint: survival chances of screen-detected breast and cervical cancers
Endpoint domain: Mortality/survival
Primary endpoint: Serum concentrations of IL-6, IL-8, and IL-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality-adjusted life years (QALYs) gained
Endpoint domain: Physiological/clinical
Primary endpoint: Life years gained
Endpoint domain: Physiological/clinical
Primary endpoint: Visit satisfaction rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total procedure duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: UFOV improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychological measure of PS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: 5-year MACCE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5-year QOL status
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: reduced emotion dysregulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reductions on a composite score of preservative cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NRS on movement at 12 h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction of pain service
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular hospitalization or death due to any cause
Endpoint domain: Mortality/survival
Primary endpoint: Change in brain parenchymal fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expanded Disability Status Scale score of 3.5 or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip strength post EIMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SmO2 re-saturation rate post EIMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: awakening frequency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Improvement in production of velar sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Easier or better speech
Endpoint domain: Life impact
Endpoint subdomain: Communication functioning
Primary endpoint: Better transport of food or saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Success rate of RBFPDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction and summary OHIP-49 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: treatment satisfaction rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: preference for dosing frequency
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Device usage hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with grade ≥2 genitourinary AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma DPV concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the ring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General knowledge of immunization and self‐reported practice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gathering immunization information from community
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication with mothers about immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of Leopold's maneuvers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of Mulligan mobilisation with movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement with management plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increased mean relative powers of LD flux signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased resting LD flux
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased peak LD flux as a function of baseline during LTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal Epithelial Thickness (CET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in NAFLD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UE flexor synergy improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women with stage III or IV disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Hb responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sensitivity in determining presence of clinically significant CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity in determining presence of clinically significant CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IKDC Subjective Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side-to-side difference in AP knee laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamstring muscle strength index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Harris hip function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: feelings of social connection
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: overall survival benefit
Endpoint domain: Mortality/survival
Primary endpoint: 123I-FP-CIT-SPECT uptake change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: peak knee valgus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hip flexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: knee valgus moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Intention level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Achieving a 5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of high autistic characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of intraoperative hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median value of glycemic variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LA emptying fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LA function index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of first relapse to opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days of illicit opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment adherence rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Nonanastomotic biliary strictures
Endpoint domain: Adverse events/effects
Primary endpoint: Postreperfusion syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Early allograft dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: loneliness score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Five-year progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding Academic Research Consortium type 3 to 5 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of lower extremity injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean traveled distance in ISWT (Incremental Shuttle Walk Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathologic treatment response of ≥20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in physical violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in psychological violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in sexual violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coverage of home-based newborn care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Care-seeking for maternal and neonatal complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length-adjusted weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTP score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-month mRS ≤1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FRAX®-defined major osteoporotic fractures (MOF)
Endpoint domain: Mortality/survival
Primary endpoint: Hematoma resolution rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative PHE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable functional outcomes (modified Rankin Scale score ≤ 3)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to severe flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in NIHSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in BI index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Use of marijuana in high-risk situations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of app usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: prognostic benefit to prophylactic complete revascularization
Endpoint domain: Mortality/survival
Primary endpoint: learning index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: working memory on manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: updating capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Support for restricting aducanumab access
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to enroll family member in trial
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Agreement on withdrawal of aducanumab if trials fail
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CAPS-5 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reliable improvement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRMSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mEGT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TA (acquisition time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification accuracy of HR ranges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification accuracy of SpO2 ranges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in IIEF-EF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving MCID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate memory gains
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Working memory span improvements
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Accuracy of prediction for NPV trigger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity for NPV trigger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity for NPV trigger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of having subsequent affective disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of positive cultures at 90 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Median bacterial count at 90 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: reductions in total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reductions in triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reductions in glycated hemoglobin (A1cHb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute JPS errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MVIC (Maximum Voluntary Isometric Contraction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in clinical symptoms of the disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of blood flow in the capillaries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Odds of moderate compared to heavy cannabis use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in cannabis withdrawal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASDAS-CRP improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: r-axSpA activity decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in pneumococcal culture-positive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Decline in NTHi culture-positive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Decline in overall culture-positive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient care record accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary outcome measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients alive and free of respiratory failure at Day 28
Endpoint domain: Mortality/survival
Primary endpoint: increased EQ‐5D score from 0 to 48 weeks
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: range of shoulder motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-rated daytime xerostomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physician-rated xerostomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Face validity of the Spanish-translated survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Belief that toddler milk is as healthy or healthier than cow's milk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to give toddler milk to their child
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances